Nephros (NEPH) Accounts Payables (2010 - 2026)

Nephros' Accounts Payables history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 162.66% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 162.66% YoY), while the FY2025 annual figure was $914000.0, up 40.83% from the prior year.
• Accounts Payables was $1.5 million for Q1 2026 at Nephros, up from $914000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.5 million in Q1 2026 to a low of $302000.0 in Q2 2023.
• Historically, Accounts Payables has averaged $844000.0 across 5 years, with a median of $805000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables tumbled 78.6% in 2023, then surged 283.77% in 2024.
• A 5-year view of Accounts Payables shows it stood at $740000.0 in 2022, then advanced by 17.97% to $873000.0 in 2023, then retreated by 25.66% to $649000.0 in 2024, then soared by 40.83% to $914000.0 in 2025, then jumped by 60.07% to $1.5 million in 2026.
• The last three Accounts Payables figures came in at $1.5 million (Q1 2026), $914000.0 (Q4 2025), and $936000.0 (Q3 2025), per Business Quant data.